ACE2 and Myocardial fibrosis: In a recent study in which we measured both circulating and tissue levels of ACE2 in humans [26], we reported that reduced tissue levels were associated with elevated plasma ACE2 activity and that those with the highest plasma ACE2 activity had reduced tissue ACE2 expression and more severe myocardial fibrosis, an important predictor of death.